IL9 and malignant colon neoplasm: Finally, genetic or pharmacological blockade of autophagy in TH9 cells not only enhances their anticancer functions in an IL-9-dependent manner against melanoma upon adoptive transfer but also in vivo in both established colon cancer and melanoma.